Food prioritized in FDA Globalization Act: The House Energy and Commerce Committee will break out food safety provisions from the FDA Globalization Act, H.R. 759, as a separate bill since Chairman Henry Waxman and others in Congress have made securing the food supply a top priority. Speaking at the Food and Drug Law Institute/FDA conference in Washington April 23, Energy and Commerce majority counsel Rachel Sher explained the committee is attempting to squeeze in work on food safety with other top legislative priorities, namely health care reform and carbon emission cap-and-trade. In addition to using FDAGA "as a foundation to draft a strong food safety bill," as Waxman, D-Calif., has suggested, Sher said the chairman "intends to look closely" at Rep. Rosa DeLauro's Food Safety Modernization Act, H.R. 875, in which the Connecticut Democrat proposes placing food safety in a new agency outside FDA. Sher said Waxman is seeking additional authorities for FDA, including access to manufacturer records and mandatory recall. While Waxman would prefer not to resort to user fees to fund the agency's food safety initiatives, "the need for a stronger food program is so dire that if it appears the monies we're able to come up with through the appropriations process are inadequate, he believes we must look to regulated industry to help," Sher said. The committee will address drug, device and cosmetic provisions of FDAGA after food safety, Sher added. Michigan Democrat John Dingell introduced FDAGA in January (1"The Tan Sheet" March 16, 2009, p. 16)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
HHS Secretary Kennedy's new ACIP appointments include multiple members of anti-vaccine groups and people who have spread misinformation about COVID-19 vaccines.
Commissioner Martin Makary told staff that plans are being developed to centralize HR, IT, travel and other functions, which were heavily impacted by the 1 April reduction-in-force.
The House Appropriations Committee wants an analysis of how issues that led to CRLs could have been resolved within the first review cycle and seeks an agency crackdown on counterfeit GLP-1 agonists.